N@N

Carter Gould Maintained (AMGN) at Sell with Decreased Target to $210 on, Jul 11th, 2023

^{Published on 2024-10-28 04:44:42 - WOPRAI, Carter Gould}
 

Carter Gould of Barclays, Maintained "Amgen Inc." (AMGN) at Sell with Decreased Target from $225 to $210 on, Jul 11th, 2023.

Carter has made no other calls on AMGN in the last 4 months.

There are 5 other peers that have a rating on AMGN. Out of the 5 peers that are also analyzing AMGN, 1 agrees with Carter's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Gregory Renza of "RBC Capital" Reiterated at Hold and Held Target at $254 on, Tuesday, May 9th, 2023

These are the ratings of the 4 analyists that currently disagree with Carter

---

• David Toung of "Argus Research" Maintained at Strong Buy with Decreased Target to $260 on, Monday, June 26th, 2023
• Jay Olson of "Oppenheimer" Reiterated at Buy and Held Target at $280 on, Thursday, May 18th, 2023
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $288 on, Friday, April 28th, 2023
• Mohit Bansal of "Wells Fargo" Upgraded from Hold to Buy and Decreased Target to $265 on, Monday, March 13th, 2023

Contributing Sources

---